-
Markets
-
Aktien
Sustainable finance2025 Euronext ESG Trends ReportWeiterlesenA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesWeiterlesenThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeWeiterlesenInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondWeiterlesenFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesWeiterlesenTrade mini bond futures on main European government bonds
-
Rohstoffe
- Übersicht
- Kurse überblick
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesWeiterlesenEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameWeiterlesenJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Nanobiotix
Identification
Instrument name
NANOBIOTIX
Symbol
NANO
ISIN code
FR0011341205
Exchange / Market
Euronext
Trading location
Paris
Products family
Stocks
ICB
Biotechnology
Activity description
Nanobiotix est spécialisé dans le développement de technologies basées sur les nanoparticules destinées au traitement des cancers de manière sûre et non invasive. La technologie de Nanobiotix, NanoXray, vise à améliorer l’efficacité de radiothérapie en limitant la tolérance des tissus sains aux radiations qui doivent nécessairement les traverser pour atteindre les tissus tumoraux.
Source: Cofisem
Website address
http://www.nanobiotix.com
Operation
IPO date
Mo. 29/10/2012
IPO type
Introduction par offre publique
IPO price
Fourchette de prix indicative : 5,04 EUR – 6,16 EUR (le "Prix de l'Offre")
IPO type
Initial Public offering
Catégorie
IPO
Operation calendar
23 October 2012 Listing date
29 October 2012 First Trading date